(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 19.7% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.15%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Glaukos's revenue in 2025 is $432,953,000.On average, 9 Wall Street analysts forecast GKOS's revenue for 2025 to be $27,741,278,362, with the lowest GKOS revenue forecast at $27,484,981,270, and the highest GKOS revenue forecast at $27,949,516,164. On average, 9 Wall Street analysts forecast GKOS's revenue for 2026 to be $35,230,842,564, with the lowest GKOS revenue forecast at $34,325,114,219, and the highest GKOS revenue forecast at $36,209,634,792.
In 2027, GKOS is forecast to generate $43,799,045,322 in revenue, with the lowest revenue forecast at $42,492,325,868 and the highest revenue forecast at $47,056,237,833.